Affordable Access

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy.

Authors
Type
Published Article
Journal
Blood
Publication Date
Volume
82
Issue
9
Pages
2624–2633
Identifiers
PMID: 8219217
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments